BI
AZN icon

Binnacle Investments’s AstraZeneca AZN Stock Holding History

Binnacle Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$50.6K Buy
330
+59
+22% +$8.93K 0.03% 150
2025
Q2 		$37.9K Buy
271
+29
+12% +$4.06K 0.02% 160
2025
Q1 		$35.6K Buy
+242
New +$35K 0.03% 154

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Binnacle Investments's AZN Position: Q3 2025 in Review

Binnacle Investments increased its AstraZeneca (AZN) stake by 22% in Q3 2025, buying an estimated $8.93K and bringing the position to 330 shares worth $50.6K. The position accounts for 0.03% of the portfolio, ranked #150.

Binnacle Investments first reported a position in AZN in Q1 2025 and has held it in 3 quarters since. 1,287 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Binnacle Investments held 330 shares of AstraZeneca worth $50.6K as of Q3 2025.
  • Binnacle Investments bought 59 AstraZeneca shares in Q3 2025, an estimated $8.93K.
  • AstraZeneca made up 0.03% of Binnacle Investments's portfolio in Q3 2025, its #150 holding.
  • Binnacle Investments first reported a position in AstraZeneca in Q1 2025 and has held it in 3 quarters since.
  • 1,287 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.